PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.42%
Revenue growth above 1.5x 6617.T's 10.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
53.62%
Gross profit growth similar to 6617.T's 54.75%. Walter Schloss would assume both firms track common industry trends.
250.85%
EBIT growth below 50% of 6617.T's 811.07%. Michael Burry would suspect deeper competitive or cost structure issues.
256.00%
Operating income growth under 50% of 6617.T's 1219.28%. Michael Burry would be concerned about deeper cost or sales issues.
171.88%
Net income growth under 50% of 6617.T's 929.32%. Michael Burry would suspect the firm is falling well behind a key competitor.
171.96%
EPS growth under 50% of 6617.T's 929.39%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
171.96%
Diluted EPS growth under 50% of 6617.T's 929.39%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Share reduction while 6617.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 6617.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.26%
Negative 10Y revenue/share CAGR while 6617.T stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-27.58%
Negative 5Y CAGR while 6617.T stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-44.20%
Negative 3Y CAGR while 6617.T stands at 19.99%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
101.52%
10Y net income/share CAGR of 101.52% while 6617.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-49.90%
Negative 5Y net income/share CAGR while 6617.T is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-72.56%
Negative 3Y CAGR while 6617.T is 305.56%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
214.79%
Positive 5Y equity/share CAGR while 6617.T is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
11.06%
3Y equity/share CAGR above 1.5x 6617.T's 2.68%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.99%
AR growth well above 6617.T's 7.01%. Michael Burry fears inflated revenue or higher default risk in the near future.
16.65%
Inventory growth well above 6617.T's 6.23%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
16.62%
Asset growth above 1.5x 6617.T's 4.18%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.81%
BV/share growth above 1.5x 6617.T's 2.93%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
18.95%
Debt growth far above 6617.T's 33.67%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.19%
R&D growth of 4.19% while 6617.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
0.31%
We expand SG&A while 6617.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.